Literature DB >> 26477066

[Clinical Results of Diffractive Multifocal Intraocular Lens Implantation after Laser In Situ Keratomileusis].

Mami Yoshino, Keiichiro Minami, Manabu Hirasawa, Shinichi Oki, Hiroko Bissen-Miyajima.   

Abstract

PURPOSE: To evaluate the visual performance in eyes with diffractive intraocular lenses (IOLs) after laser in situ keratomileusis (LASIK).
METHODS: This single-center retrospective study evaluated eyes that had diffractive multifocal IOL implantation after previous LASIK or not treated with LASIK (controls). The outcomes' measures were the visual acuities (VAs) at distance and near, spherical equivalent (SE) and contrast sensitivity at one month postoperatively.
RESULTS: The study evaluated 40 eyes of 33 patients. The mean uncorrected logMAR VAs were -0.05 ± 0.13/0.00 ± 0.14 (LASIK group/control group) at distance and 0.10 ± 0.13/0.16 ± 0.18 at near. There was no statistically significant difference between the 2 groups at the VAs. The SE of the LASIK group was -0.06 ± 0.39 D, significantly lower than the control group (0.22 ± 0.45 D) (p < 0.05). The contrast sensitivity of the LASIK group at high spatial frequency was lower than the control group (p < 0.05).
CONCLUSION: After LASIK, the diffractive multifocal IOL provided good uncorrected distance and near VAs. However, decrease in contrast sensitivity should be considered.

Entities:  

Mesh:

Year:  2015        PMID: 26477066

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  2 in total

1.  Presbyopia-Correcting Intraocular Lenses Implantation in Eyes After Corneal Refractive Laser Surgery: A Meta-Analysis and Systematic Review.

Authors:  Yang Sun; Yingying Hong; Xianfang Rong; Yinghong Ji
Journal:  Front Med (Lausanne)       Date:  2022-04-11

2.  Influence of extended depth of focus intraocular lenses on visual field sensitivity.

Authors:  Makiko Takahashi; Chiemi Yamashiro; Takuya Yoshimoto; Yuka Kobayashi; Fumiaki Higashijima; Masaaki Kobayashi; Makoto Hatano; Manami Ohta; Tomohiko Nagai; Shinichiro Teranishi; Katsuyoshi Suzuki; Ryu Takabatake; Kazuhiro Kimura
Journal:  PLoS One       Date:  2020-09-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.